Cell Reports
Volume 36, Issue 11, 14 September 2021, 109697
Journal home page for Cell Reports

Article
The transcription factor BCL11A defines distinct subsets of midbrain dopaminergic neurons

https://doi.org/10.1016/j.celrep.2021.109697Get rights and content
Under a Creative Commons license
open access

Highlights

  • Bcl11a is expressed in a subset of murine and human dopaminergic neurons

  • Bcl11a+ dopaminergic neurons form a highly specific subcircuit in mouse

  • Bcl11a+ substantia nigra neurons are particularly vulnerable to neurodegeneration

  • Bcl11a inactivation increases vulnerability and impairs motor behavior in mice

Summary

Midbrain dopaminergic (mDA) neurons are diverse in their projection targets, effect on behavior, and susceptibility to neurodegeneration. Little is known about the molecular mechanisms establishing this diversity during development. We show that the transcription factor BCL11A is expressed in a subset of mDA neurons in the developing and adult murine brain and in a subpopulation of pluripotent-stem-cell-derived human mDA neurons. By combining intersectional labeling and viral-mediated tracing, we demonstrate that Bcl11a-expressing mDA neurons form a highly specific subcircuit within the murine dopaminergic system. In the substantia nigra, the Bcl11a-expressing mDA subset is particularly vulnerable to neurodegeneration upon α-synuclein overexpression or oxidative stress. Inactivation of Bcl11a in murine mDA neurons increases this susceptibility further, alters the distribution of mDA neurons, and results in deficits in skilled motor behavior. In summary, BCL11A defines mDA subpopulations with highly distinctive characteristics and is required for establishing and maintaining their normal physiology.

Keywords

dopaminergic neurons
development
neuronal diversity
circuits
behavior
transcription factor
neurodegeneration
mouse
iPSCs
alpha-synuclein

Data and code availability

  • The accession number for the scRNA sequencing is ArrayExpress: E-MTAB-9154, as reported in Fernandes et al. (2020). Imaging and quantitative data have been deposited at Mendeley and are publicly available as of the date of publication. DOIs are listed in the Key resources table.

  • This paper does not report original code.

  • Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

Cited by (0)

10

Queensland Brain Institute, University of Queensland, Brisbane, Queensland, 4072, Australia

11

Mater Research Institute-University of Queensland, TRI Building, Brisbane, Queensland, 4102, Australia

12

Department of Epileptology, Neurology, RWTH Aachen University, 52074 Aachen, Germany

13

Lead contact